Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO studyComplementary and alternative medicine in oncology

[1] Ashar B(1996)Shark cartilage-induced hepatitis Ann Intern Med 125 780-781

[2] Vargo E(2017)Use of complementary and alternative medicine (CAM) in cancer patients: An Italian multicenter survey Oncotarget 8 24401-24414

[3] Berretta M(2014)Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in Italy J Pain Symptom Manag 47 26-34

[4] Della Pepa C(2000)Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions J Clin Oncol Off J Am Soc Clin Oncol 18 2515-2521

[5] Tralongo P(2006)An evaluation of the biological and toxicological properties of J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 24 103-154

[6] Bonacchi A(2015) (Miller), Recenti Prog Med 106 601-607

[7] Fazzi L(2000)Complementary and alternative medicine in oncology Phytomed Int J Phytother Phytopharm 7 273-282

[8] Toccafondi A(1999)An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures N Engl J Med 340 1733-1739

[9] Boon H(1998)Use of alternative medicine by women with early-stage breast cancer JAMA 280 1569-1575

[10] Stewart M(2002)Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey Ann Intern Med 136 42-53

[1] Ashar B(1996)Shark cartilage-induced hepatitis Ann Intern Med 125 780-781

[2] Vargo E(2017)Use of complementary and alternative medicine (CAM) in cancer patients: An Italian multicenter survey Oncotarget 8 24401-24414

[3] Berretta M(2014)Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in Italy J Pain Symptom Manag 47 26-34

[4] Della Pepa C(2000)Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions J Clin Oncol Off J Am Soc Clin Oncol 18 2515-2521

[5] Tralongo P(2006)An evaluation of the biological and toxicological properties of J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 24 103-154

[6] Bonacchi A(2015) (Miller), Recenti Prog Med 106 601-607

[7] Fazzi L(2000)Complementary and alternative medicine in oncology Phytomed Int J Phytother Phytopharm 7 273-282

[8] Toccafondi A(1999)An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures N Engl J Med 340 1733-1739

[9] Boon H(1998)Use of alternative medicine by women with early-stage breast cancer JAMA 280 1569-1575

[10] Stewart M(2002)Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey Ann Intern Med 136 42-53